Formulation Development
FORMULATION DEVELOPMENT WHITE PAPERS & ARTICLES
-
![The Art of Protein Expression-FutureFields]( "The Art Of Protein Expression: A Guide To Understanding Difficult-To-Express Proteins")
The Art Of Protein Expression: A Guide To Understanding Difficult-To-Express ProteinsProtein expression failures often result from misfolding, PTMs, assembly issues, insolubility, and toxicity. Understanding their interplay can improve yields.
-
![GettyImages-2280454860-scientist-liver-organ-research]( "The Continuing Challenge Of Drug-Induced Liver Injury")
The Continuing Challenge Of Drug-Induced Liver InjuryRecent liver safety concerns highlight the limits of conventional preclinical testing. Human-relevant models could help researchers detect drug-induced liver injury earlier and reduce costly setbacks.
-
![Smart Manufacturing facility-GettyImages-1938951579]( "Safety First: Considerations When Formulating High Potency Compounds")
Safety First: Considerations When Formulating High Potency CompoundsDeveloping highly potent APIs comes with unique challenges. Explore strategies for managing risk, protecting personnel, and advancing programs with confidence.
-
![GettyImages-1585548490-modular-facility-laboratory-drug-development]( "Insights Into Evionnaz's new R&D Center")
Insights Into Evionnaz's new R&D CenterPharmaceutical innovation depends on speed and smarter decisions. Discover how advanced R&D technologies and real-time insights are helping accelerate development.
-
![Three Success Factors To Accelerate Your Program To Clinical Trial_Siegfried]( "Three Success Factors To Accelerate Your Program To Clinical Trial")
Three Success Factors To Accelerate Your Program To Clinical TrialAccelerating clinical timelines starts with a strong foundation. Discover how smart development strategies can reduce risk, conserve resources, and support future scale-up.
FORMULATION DEVELOPMENT APPLICATIONS & STUDIES
-
![GettyImages-1370147753-white-tablets-pill-bottle]( "Formulation And Process Challenges For A Needle-Shaped API")
Formulation And Process Challenges For A Needle-Shaped APIManaging challenging active pharmaceutical ingredient crystal structures and choosing dry granulation over wet granulation requires strategic processing choices.
-
![From Sequence To Scale In Seven Months_Future Fields]( "From Sequence To Scale In Seven Months")
From Sequence To Scale In Seven MonthsAccelerate recombinant protein development from sequence to scale while maintaining stable expression, manufacturing efficiency, and critical quality attributes.
-
![Protein that mutates in the development of cancer-GettyImages-1466537448]( "Characterizing Protein Stability By DSC")
Characterizing Protein Stability By DSCDiscover how differential scanning calorimetry quantifies the thermodynamic forces behind protein folding and stability, providing valuable insight for protein engineering and therapeutic formulation.
-
![GettyImages-2202060913-protein-structure-blue-and-white-3d]( "Life Science Applications Of DSC")
Life Science Applications Of DSCLearn how Differential Scanning Calorimetry directly measures macromolecular stability, unfolding, and binding interactions, providing valuable thermodynamic insights for protein engineering.
-
![GettyImages-1167352850-antibody-green]( "Streamline Antibody Analysis For Faster Protein Characterization")
Streamline Antibody Analysis For Faster Protein CharacterizationStrengthen your antibody characterization. Explore approaches for improving sizing accuracy, resolving heterogeneity, and generating reproducible data across demanding biopharmaceutical workflows.
FORMULATION DEVELOPMENT PRODUCTS & SERVICES
Curia’s discovery biology team accelerates your program toward the clinic and commercialization with our best-in-class, customizable solutions.
The iCELLis™ bioreactor system is an automated, single-use, fixed-bed bioreactor that provides excellent cell growth conditions for adherent cells.
Find what you need to move your Alzheimer’s research forward faster, with antibodies to 95% of core AD genes validated in imaging applications with human samples.
The Powder Rheology Accessory expands the DHR’s capabilities to powders, enabling the characterization of behaviors during storage, dispensing, processing, and end-use.
From safety considerations to kid-friendly dosing, we can help you get your pediatric formulation right.
Integrated drug discovery greatly benefits programs by blending various scientific disciplines into a unified team focused on your project.
Measure heat flow, weight loss, dimension change, or mechanical properties as a function of temperature.
Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to inadequate insulin production or impaired insulin utilization, commonly known as insulin resistance.
FORMULATION DEVELOPMENT SOLUTIONS
- MaxPeak Premier Columns For Intact And Subunit Protein Analysis
- Oligonucleotide Discovery And Development
- R&D And Analytical Services
- Mass Detection For Undergraduates
- Neurodegeneration Research
- Is NSA Sabotaging Your Lab's Productivity
- MaxPeak Premier For Glycan Analysis
- A Viral Safety Solution Designed To Provide Retention Assurance And Productivity
- Speed, Scale, And Supply With Innovative Cell Culture Solutions
- Unlock Amorphous Solubility Enhancement For Challenging Compounds
PHARMACEUTICAL AND FORMULATION DEVELOPMENT NEWS
- ROSS 600-Gallon ASME Pressure Vessel For High-Pressure Processing
- METTLER TOLEDO Expands Foreign Material Re-Inspection Services With New Dallas Facility
- Serán Bioscience Strengthens Spray Dry Capabilities With Growth Investment From Biospring Partners To Accelerate Commercial Expansion And Meet Surging Customer Demand
- Rottendorf Pharma Is CDMO Leadership Award Winner 2025
- Top Employer 2025: Rottendorf Pharma Receives International Award
- New Gerteis Roller Compactors: Rottendorf Pharma Invests Millions In State-Of-The-Art Technology
- Rottendorf Pharma To Double Long-Term Manufacturing Capacity With New Campus
- Future Fields Closes Oversubscribed $8M Series A to Turn Flies Into Bioreactors That Address Undruggable Diseases
- Germfree Announces New Chief Financial Officer And Chief Commercial Officer
- Siegfried Delivers Profitable Growth And Confirms Outlook